What is the ticker symbol for AIM ImmunoTech?

AIM ImmunoTech trades under the ticker AIM on AMEX.

What sector does AIM ImmunoTech operate in?

AIM ImmunoTech is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AIM in a portfolio?

PortView shows AIM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

AIM ImmunoTech (AIM) Stock Analysis

AMEXHealthcareBiotechnology

$0.23-2.03%

1-year price historyRange $0.22 – $2.71

52-week range$0.23

$0.19$2.89

What AIM ImmunoTech does

AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company, originally incorporated in 1966, was formerly known as Hemispherx Biopharma, Inc. until its name change in August 2019.

Key metrics

Market cap

$786,898

P/E (TTM)

-0.04

EPS (TTM)

$-6.38

Beta

1.19

Dividend yield

0.00%

Revenue / share

$0.01

50-day avg

$0.27

200-day avg

$0.73

52-week high

$2.89

52-week low

$0.19

CEO

Thomas K. Equels

ETFs linked to AIM

Broad-market and Healthcare sector ETFs an investor holding AIM ImmunoTech is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AIM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AIM in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for AIM ImmunoTech?: AIM ImmunoTech trades under the ticker AIM on AMEX.
Which exchange is AIM listed on?: AIM is listed on AMEX.
What sector does AIM ImmunoTech operate in?: AIM ImmunoTech is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AIM in a portfolio?: PortView shows AIM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.